Press Releases

Date Title
10/26/11 AVI BioPharma Announces Third Quarter 2011 Financial Results and Corporate Update Conference Call
10/21/11 AVI BioPharma's RNA-Based Therapeutics for Treatment of Ebola and Marburg Viruses Show Positive Safety Data in First Five of Six Cohorts of Phase 1 Clinical Studies
10/18/11 AVI BioPharma Announces Data Presentation for RNA-Based Duchenne Muscular Dystrophy Drug Candidate at the 16th International World Muscle Society Congress
9/19/11 AVI BioPharma Announces Presentations at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting
9/14/11 AVI BioPharma to Present Company Overview at the UBS Global Life Sciences Conference
9/1/11 AVI BioPharma to Present Company Overview at the Stifel Nicolaus 2011 Healthcare Conference
8/15/11 AVI BioPharma Initiates Dosing in Phase 2 Study of Eteplirsen in Duchenne Muscular Dystrophy Patients
8/10/11 AVI BioPharma to Present Company Overview at the Wedbush Securities Life Science Conference
8/4/11 AVI BioPharma Announces Second Quarter 2011 Financial Results and Recent Corporate Developments
7/28/11 AVI BioPharma Announces Second Quarter 2011 Financial Results and Corporate Update Conference Call
Displaying 561 - 570 of 812